Literature DB >> 30008390

Molecular and functional characterization of circulating extracellular vesicles from diabetic patients with and without retinopathy and healthy subjects.

Aurora Mazzeo1, Elena Beltramo2, Tatiana Lopatina3, Chiara Gai4, Marina Trento5, Massimo Porta6.   

Abstract

Diabetic retinopathy is a sight-threatening complication of diabetes, characterized by loss of retinal pericytes and abnormal angiogenesis. We previously demonstrated that extracellular vesicles (EVs) derived from mesenchymal stem cells cultured in diabetic-like conditions are able to enter the pericytes, causing their detachment and migration, and stimulating angiogenesis in vitro. The purpose of this work was the molecular and functional characterization of EVs derived from diabetic subjects with or without diabetic retinopathy, compared with healthy controls. Characterization of EVs extracted from serum/plasma of diabetic patients with or without retinopathy, and healthy controls, was performed by FACS and microarray analysis of microRNA (miRNA) content. Relevant miRNA expression was validated through qRT-PCR. EV influence on pericyte detachment, angiogenesis and permeability of the blood-retinal barrier was also investigated. Diabetic subjects had a 2.5 fold higher EV concentration than controls, while expression of surface molecules was unchanged. Microarray analysis revealed 11 differentially expressed miRNAs. Three of them (miR-150-5p, miR-21-3p and miR-30b-5p) were confirmed by qRT-PCR. Plasma EVs from subjects with diabetic retinopathy induced pericyte detachment and pericyte/endothelial cell migration, increased the permeability of pericyte/endothelial cell bilayers and the formation of vessel-like structures, when compared with EVs from controls. In conclusion, circulating EVs show differences between diabetic patients and healthy subjects. EVs extracted from plasma of diabetic retinopathy patients are able to induce features of retinopathy in in vitro models of retinal microvasculature. Our data suggest a role for miR-150-5p, miR-21-3p and miR-30b-5p as potential biomarkers of the onset of diabetic retinopathy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Diabetes; Diabetic retinopathy; Extracellular vesicles; Pericytes; miR-150-5p; miR-21-3p; miR-30b-5p

Mesh:

Substances:

Year:  2018        PMID: 30008390     DOI: 10.1016/j.exer.2018.07.003

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  23 in total

Review 1.  Extracellular Vesicles in Type 1 Diabetes: Messengers and Regulators.

Authors:  Sarita Negi; Alissa K Rutman; Steven Paraskevas
Journal:  Curr Diab Rep       Date:  2019-07-31       Impact factor: 4.810

Review 2.  The emerging role of extracellular vesicles in retinal diseases.

Authors:  Fengtian Sun; Wenrong Xu; Hui Qian
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  In-depth transcriptomic analysis of human retina reveals molecular mechanisms underlying diabetic retinopathy.

Authors:  Kolja Becker; Holger Klein; Eric Simon; Coralie Viollet; Christian Haslinger; German Leparc; Christian Schultheis; Victor Chong; Markus H Kuehn; Francesc Fernandez-Albert; Remko A Bakker
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

Review 4.  Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease.

Authors:  Allison Mathiesen; Tyree Hamilton; Nigeste Carter; Michael Brown; William McPheat; Anca Dobrian
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

Review 5.  Signal transduction mechanism of exosomes in diabetic complications (Review).

Authors:  Xueting Li; Shuo Shi; Dehuai Jing; Xinjian Li; Bin Zhang; Qingli Bie
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

6.  Human bone marrow contains high levels of extracellular vesicles with a tissue-specific subtype distribution.

Authors:  Andreas Rank; Rienk Nieuwland; Anton Köhler; Cordula Franz; Johanna Waidhauser; Bettina Toth
Journal:  PLoS One       Date:  2018-12-06       Impact factor: 3.240

Review 7.  MicroRNAs as biomarkers of diabetic retinopathy and disease progression.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2019-11       Impact factor: 5.135

8.  Identification of Diagnostic and Prognostic microRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy.

Authors:  Parviz Mammadzada; Juliette Bayle; Johann Gudmundsson; Anders Kvanta; Helder André
Journal:  J Clin Med       Date:  2019-12-15       Impact factor: 4.241

9.  MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy.

Authors:  Marta Greco; Eusebio Chiefari; Francesca Accattato; Domenica M Corigliano; Biagio Arcidiacono; Maria Mirabelli; Rossella Liguori; Francesco S Brunetti; Salvatore A Pullano; Vincenzo Scorcia; Antonino S Fiorillo; Daniela P Foti; Antonio Brunetti
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-04       Impact factor: 5.555

10.  Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy.

Authors:  E R Polina; F M Oliveira; R C Sbruzzi; D Crispim; L H Canani; K G Santos
Journal:  Endocr Connect       Date:  2019-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.